MetLife, Inc.
NYSEMET heads into the back half of August with analysts chasing the stock higher and options traders growing notably more defensive — a tension worth unpacking. The analyst upgrade cycle on MetLife has been relentless. Wells Fargo raised its target to $109 on Tuesday, maintaining an Overweight rating, just days after JP Morgan held its own Overweight and bumped to $108. Those moves…
MET short interest falls 20.9% in one week to 1.67% of float, lowest level in recent months.
MET heads into the back half of August with analysts chasing the stock higher and options traders growing notably more defensive — a tension worth unpacking. The analyst upgrade cycle on MetLife has been relentless.…
MetLife announced on August 5, 2026 a $3 billion equity buyback program. The authorization allows the company to repurchase its own shares up to that dollar limit — no shares have necessarily been bought yet. For…
Snapshot as of 20 Sept 2026
MetLife authorized a share repurchase program on August 5, 2026. The announcement covers a buyback plan — an authorization to repurchase the company's own shares. An authorization is not a purchase; it gives the…
MetLife reports Q2 results today with options traders showing the most defensive positioning in weeks — even as the analyst community remains uniformly bullish. The clearest signal heading into the print is in options.…
MetLife enters its August 5 earnings report on the back of a remarkable analyst consensus shift — one that has yet to be fully tested by the numbers. The Street has moved decisively bullish in recent weeks. JP Morgan…
MET heads into its August 5 earnings report with one of the cleanest analyst upgrade cycles in the insurance sector this summer — ten firms lifting price targets in under three weeks, and the stock still trading below…
MetLife heads into the final stretch before its August 5 earnings print with the Street actively upgrading its view and the stock trading at a six-month high. The analyst activity this week has been unusually…
MetLife enters the back half of June having quietly outrun most of its life-insurance peers this week, with the stock up 0.7% to $88.03 while the closest comparables PRU and UNM slipped into the red. The more…
MetLife reports second-quarter results on June 16 against a backdrop of unusual momentum: the stock has climbed 13% over the past month to $88.84, and the Street has spent the last several weeks upgrading its view of…
MetLife enters its next reporting cycle with the Street upgrading price targets and short sellers quietly rebuilding positions — a combination that makes this week's price action worth watching closely. The analyst…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MET — free to start on ORTEX.
Sign up for free →Open MET on ORTEX